Atlas Trials

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Clinical trial NCT05149365 · COMPLETED

Trial details

NCT number
NCT05149365
Sponsor
The First Affiliated Hospital of Soochow University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute-graft-versus-host DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
Start date
2021-12-22
Primary completion
2023-09-24
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.